Displaying 25 - 36 of 41
Immune-Mediated and Cholestatic Diseases

Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Personal priorities

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

PFIC in practice: Paediatric and adult case studies of patients with idiopathic cholestasis

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Unmet needs in PBC: the patient perspective

Unmet needs in PBC: the patient perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome & objectives

Welcome & objectives

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Key considerations in the management of cirrhosis in PBC

Key considerations in the management of cirrhosis in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Does our increasing knowledge of PBC pathogenesis affect early management?

Does our increasing knowledge of PBC pathogenesis affect early management?

Webcasts
View